Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (225320)	2/8/2022 12:15:50 AM
From: i-node	Read Replies (1) \| Respond to of 361470

What do you say about this summary of findings? In summary, ivermectin treatment is associated with: Faster viral clearanceShorter duration of hospitalisation43% higher rate of clinical recovery83% improvement in survival rate medicalupdateonline.com

To: J_F_Shepard who wrote (225320)	2/8/2022 12:22:04 AM
From: i-node	Read Replies (1) \| Respond to of 361470

This is one of several at the li k. “ Data that further illuminates the potential protective role of ivermectin against COVID-19 come from a study of nursing home residents in France which reported that in a facility that suffered a scabies outbreak where all 69 residents and 52 staff were treated with ivermectin, 41they found that during the period surrounding this event, 7 of the 69 residents fell ill with COVID-19 (10.1%). In this group with an average age of 90 years, only one resident required oxygen support and no resident died. In a matched control group of residents from surrounding facilities, they found 22.6% of residents fell ill and 4.9% died. Further evidence supporting the efficacy of ivermectin as a prophylaxis agent was published recently in the International Journal of Antimicrobial agents . . . ncbi.nlm.nih.gov